Related Experiment Videos
Quantitation of microalbuminuria using random urine samples
1Section of Pediatric Nephrology, Rush Medical College, Rush Children's Hospital, Chicago, IL 60612, USA. fassadi@rush.edu
Pediatric Nephrology (Berlin, Germany)
|March 5, 2002
Summary
A random urine microalbumin-creatinine ratio (U(MA)/U(Cr)) accurately monitors microalbuminuria in diabetic patients. This simple method may replace cumbersome 24-hour urine collections for assessing kidney disease risk.
Area of Science:
- Nephrology
- Diabetology
- Clinical Chemistry
Background:
- Microalbuminuria is a key indicator of diabetic kidney disease and cardiovascular complications.
- Traditional 24-hour urine collection for microalbuminuria is inconvenient and prone to errors.
- A simpler, reliable method for monitoring microalbuminuria is needed.
Purpose of the Study:
- To evaluate the correlation between the microalbumin-creatinine ratio (U(MA)/U(Cr)) in random urine samples and 24-hour microalbumin excretion.
- To determine if U(MA)/U(Cr) can serve as a practical alternative to timed urine collections for microalbuminuria assessment in pediatric patients with type 1 diabetes.
Main Methods:
- A study involving 124 urine samples from 97 pediatric patients with type 1 diabetes.
- Comparison of U(MA)/U(Cr) in a random morning voided urine sample against microalbumin quantity in a 24-hour urine collection.
- Statistical analysis to determine the correlation coefficient (r) and significance (P-value).
Main Results:
- An excellent correlation (r=0.89, P<0.001) was observed between random U(MA)/U(Cr) and 24-hour microalbumin excretion.
- Patients with >30 mg/24h microalbumin excretion consistently showed U(MA)/U(Cr) >20 microg/mg.
- U(MA)/U(Cr) <20 microg/mg suggested the absence of significant microalbuminuria.
Conclusions:
- Measurement of U(MA)/U(Cr) in a random second morning voided specimen is a simple and reliable method for monitoring microalbuminuria.
- This approach may obviate the need for 24-hour urine collections in diabetic patients.
- The findings support the use of random urine U(MA)/U(Cr) for routine screening and management of diabetic nephropathy.